Bacterial cell wall macroamphiphiles: Pathogen-/microbe-associated molecular patterns detected by mammalian innate immune system

Biochimie

Volumn 95, Issue 1, 2013, Pages 33-42

  Ray, Aurélie ^a,b   Cot, Marlène ^a,b   Puzo, Germain ^a,b   Gilleron, Martine ^a,b   Nigou, Jérôme ^a,b  

^a UNIVERSITÉ DE TOULOUSE   (France)

^b UNIVERSITÉ PAUL SABATIER   (France)

Author keywords

Bacterial lipids; Innate immunity; Toll like receptors

Indexed keywords

AMPHOPHILE; BACTERIUM LIPOPOLYSACCHARIDE; CD14 ANTIGEN; CD36 ANTIGEN; CYSTEINE; DIACYLGLYCEROL; LIPID A; LIPOPHOSPHOGLYCAN; LIPOPOLYSACCHARIDE BINDING PROTEIN; LIPOPROTEIN; LIPOTEICHOIC ACID; MANNOSIDE; PATTERN RECOGNITION RECEPTOR; PROTEIN MD 2; TOLL LIKE RECEPTOR 1; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 6;

ACTINOBACTERIA; ACYLATION; ANTIGEN RECOGNITION; BACILLUS SUBTILIS; BACTERIAL CELL WALL; BACTERIAL OUTER MEMBRANE; CLOSTRIDIUM; CORYNEBACTERIACEAE; CRYSTAL STRUCTURE; CYTOKINE RESPONSE; ENDOCYTOSIS; ENTEROCOCCUS FAECALIS; ESCHERICHIA COLI; FIRMICUTES; GERM LINE; GRAM NEGATIVE BACTERIUM; HOST RESISTANCE; INNATE IMMUNITY; INTRACELLULAR SIGNALING; LISTERIA MONOCYTOGENES; MYCOBACTERIUM FORTUITUM; MYCOBACTERIUM SMEGMATIS; MYCOPLASMA FERMENTANS; NONHUMAN; PROTEIN LOCALIZATION; PROTEIN STRUCTURE; REVIEW; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS AGALACTIAE; STREPTOCOCCUS PNEUMONIAE; X RAY CRYSTALLOGRAPHY;

BACTERIA; CELL WALL; HOST-PARASITE INTERACTIONS; HUMANS; IMMUNITY, INNATE; LIPOPOLYSACCHARIDES; TEICHOIC ACIDS; TOLL-LIKE RECEPTOR 2; TOLL-LIKE RECEPTOR 4;

BACTERIA (MICROORGANISMS); MAMMALIA; NEGIBACTERIA; POSIBACTERIA;

EID: 84870526465     PISSN: 03009084     EISSN: 61831638     Source Type: Journal    
DOI: 10.1016/j.biochi.2012.06.007     Document Type: Review

References (117)

1. R. Medzhitov Recognition of microorganisms and activation of the immune response Nature 449 2007 819 826
2. A. Iwasaki, and R. Medzhitov Regulation of adaptive immunity by the innate immune system Science 327 2010 291 295
3. S. Akira, S. Uematsu, and O. Takeuchi Pathogen recognition and innate immunity Cell 124 2006 783 801
4. E.M. Moresco, D. LaVine, and B. Beutler Toll-like receptors Curr. Biol. 21 2011 R488 R493
5. A. Pluddemann, S. Mukhopadhyay, and S. Gordon Innate immunity to intracellular pathogens: macrophage receptors and responses to microbial entry Immunol. Rev. 240 2011 11 24
6. O. Rahman, L.G. Dover, and I.C. Sutcliffe Lipoteichoic acid biosynthesis: two steps forwards, one step sideways? Trends Microbiol. 17 2009 219 225
7. W. Fischer Lipoteichoic acids and lipoglycans J.-M. Ghuysen, R. Hakenbeck, Bacterial Cell Wall 1994 Elsevier Science B.V. Amsterdam, The Netherlands 199 215
8. M.S. Jin, and J.O. Lee Structures of the toll-like receptor family and its ligand complexes Immunity 29 2008 182 191
9. J.Y. Kang, and J.O. Lee Structural biology of the Toll-like receptor family Annu. Rev. Biochem. 80 2011 917 941
10. C. Erridge, E. Bennett-Guerrero, and I.R. Poxton Structure and function of lipopolysaccharides Microbes Infect. 4 2002 837 851
11. C.R. Raetz, and C. Whitfield Lipopolysaccharide endotoxins Annu. Rev. Biochem. 71 2002 635 700
12. B.S. Park, D.H. Song, H.M. Kim, B.S. Choi, H. Lee, and J.O. Lee The structural basis of lipopolysaccharide recognition by the TLR4-MD-2 complex Nature 458 2009 1191 1195
13. T.L. Gioannini, and J.P. Weiss Regulation of interactions of Gram-negative bacterial endotoxins with mammalian cells Immunol. Res. 39 2007 249 260
14. J.I. Kim, C.J. Lee, M.S. Jin, C.H. Lee, S.G. Paik, H. Lee, and J.O. Lee Crystal structure of CD14 and its implications for lipopolysaccharide signaling J. Biol. Chem. 280 2005 11347 11351
15. J. Pugin, I.D. Heumann, A. Tomasz, V.V. Kravchenko, Y. Akamatsu, M. Nishijima, M.P. Glauser, P.S. Tobias, and R.J. Ulevitch CD14 is a pattern recognition receptor Immunity 1 1994 509 516
16. S.R. Coats, T.T. Pham, B.W. Bainbridge, R.A. Reife, and R.P. Darveau MD-2 mediates the ability of tetra-acylated and penta-acylated lipopolysaccharides to antagonize Escherichia coli lipopolysaccharide at the TLR4 signaling complex J. Immunol. 175 2005 4490 4498
17. I. Dunn-Siegrist, P. Tissieres, G. Drifte, J. Bauer, S. Moutel, and J. Pugin Toll-like receptor activation of human cells by synthetic triacylated lipid A-like molecules J. Biol. Chem. 2012
18. I.C. Sutcliffe, D.J. Harrington, and M.I. Hutchings A phylum level analysis reveals lipoprotein biosynthesis to be a fundamental property of bacteria Protein Cell 3 2012 163 170
19. P.F. Muhlradt, M. Kiess, H. Meyer, R. Sussmuth, and G. Jung Isolation, structure elucidation, and synthesis of a macrophage stimulatory lipopeptide from Mycoplasma fermentans acting at picomolar concentration J. Exp. Med. 185 1997 1951 1958
20. K. Shibata, A. Hasebe, T. Into, M. Yamada, and T. Watanabe The N-terminal lipopeptide of a 44-kDa membrane-bound lipoprotein of Mycoplasma salivarium is responsible for the expression of intercellular adhesion molecule-1 on the cell surface of normal human gingival fibroblasts J. Immunol. 165 2000 6538 6544
21. C. Robichon, D. Vidal-Ingigliardi, and A.P. Pugsley Depletion of apolipoprotein N-acyltransferase causes mislocalization of outer membrane lipoproteins in Escherichia coli J. Biol. Chem. 280 2005 974 983
22. B. Zuber, M. Chami, C. Houssin, J. Dubochet, G. Griffiths, and M. Daffe Direct visualization of the outer membrane of mycobacteria and corynebacteria in their native state J. Bacteriol. 190 2008 5672 5680
23. C. Hoffmann, A. Leis, M. Niederweis, J.M. Plitzko, and H. Engelhardt Disclosure of the mycobacterial outer membrane: cryo-electron tomography and vitreous sections reveal the lipid bilayer structure Proc. Natl. Acad. Sci. U.S.A. 105 2008 3963 3967
24. M. Rezwan, T. Grau, A. Tschumi, and P. Sander Lipoprotein synthesis in mycobacteria Microbiology 153 2007 652 658
25. K. Hoebe, P. Georgel, S. Rutschmann, X. Du, S. Mudd, K. Crozat, S. Sovath, L. Shamel, T. Hartung, U. Zahringer, and B. Beutler CD36 is a sensor of diacylglycerides Nature 433 2005 523 527
26. M.J. Jimenez-Dalmaroni, N. Xiao, A.L. Corper, P. Verdino, G.D. Ainge, D.S. Larsen, G.F. Painter, P.M. Rudd, R.A. Dwek, K. Hoebe, B. Beutler, and I.A. Wilson Soluble CD36 ectodomain binds negatively charged diacylglycerol ligands and acts as a co-receptor for TLR2 PLoS One 4 2009 e7411
27. T. Nakata, M. Yasuda, M. Fujita, H. Kataoka, K. Kiura, H. Sano, and K. Shibata CD14 directly binds to triacylated lipopeptides and facilitates recognition of the lipopeptides by the receptor complex of Toll-like receptors 2 and 1 without binding to the complex Cell Microbiol. 8 2006 1899 1909
28. T. Vasselon, P.A. Detmers, D. Charron, and A. Haziot TLR2 recognizes a bacterial lipopeptide through direct binding J. Immunol. 173 2004 7401 7405
29. T. Vasselon, W.A. Hanlon, S.D. Wright, and P.A. Detmers Toll-like receptor 2 (TLR2) mediates activation of stress-activated MAP kinase p38 J. Leukoc. Biol. 71 2002 503 510
30. A.J. Thorley, D. Grandolfo, E. Lim, P. Goldstraw, A. Young, and T.D. Tetley Innate immune responses to bacterial ligands in the peripheral human lung-role of alveolar epithelial TLR expression and signalling PLoS One 6 2011 e21827
31. H.M. Shamsul, A. Hasebe, M. Iyori, M. Ohtani, K. Kiura, D. Zhang, Y. Totsuka, and K. Shibata The Toll-like receptor 2 (TLR2) ligand FSL-1 is internalized via the clathrin-dependent endocytic pathway triggered by CD14 and CD36 but not by TLR2 Immunology 130 2010 262 272
32. G. Elson, I. Dunn-Siegrist, B. Daubeuf, and J. Pugin Contribution of Toll-like receptors to the innate immune response to Gram-negative and Gram-positive bacteria Blood 109 2007 1574 1583
33. A. Ozinsky, D.M. Underhill, J.D. Fontenot, A.M. Hajjar, K.D. Smith, C.B. Wilson, L. Schroeder, and A. Aderem The repertoire for pattern recognition of pathogens by the innate immune system is defined by cooperation between toll-like receptors Proc. Natl. Acad. Sci. U.S.A. 97 2000 13766 13771
34. O. Takeuchi, T. Kawai, P.F. Muhlradt, M. Morr, J.D. Radolf, A. Zychlinsky, K. Takeda, and S. Akira Discrimination of bacterial lipoproteins by Toll-like receptor 6 Int. Immunol. 13 2001 933 940
35. O. Takeuchi, S. Sato, T. Horiuchi, K. Hoshino, K. Takeda, Z. Dong, R.L. Modlin, and S. Akira Cutting edge: role of Toll-like receptor 1 in mediating immune response to microbial lipoproteins J. Immunol. 169 2002 10 14
36. U. Buwitt-Beckmann, H. Heine, K.H. Wiesmuller, G. Jung, R. Brock, S. Akira, and A.J. Ulmer Toll-like receptor 6-independent signaling by diacylated lipopeptides Eur. J. Immunol. 35 2005 282 289
37. U. Buwitt-Beckmann, H. Heine, K.H. Wiesmuller, G. Jung, R. Brock, S. Akira, and A.J. Ulmer TLR1- and TLR6-independent recognition of bacterial lipopeptides J. Biol. Chem. 281 2006 9049 9057
38. M.S. Jin, S.E. Kim, J.Y. Heo, M.E. Lee, H.M. Kim, S.G. Paik, H. Lee, and J.O. Lee Crystal structure of the TLR1-TLR2 heterodimer induced by binding of a tri-acylated lipopeptide Cell 130 2007 1071 1082
39. R. Spohn, U. Buwitt-Beckmann, R. Brock, G. Jung, A.J. Ulmer, and K.H. Wiesmuller Synthetic lipopeptide adjuvants and Toll-like receptor 2-structure-activity relationships Vaccine 22 2004 2494 2499
40. A.V. Kajava, and T. Vasselon A network of hydrogen bonds on the surface of TLR2 controls ligand positioning and cell signaling J. Biol. Chem. 285 2010 6227 6234
41. J.Y. Kang, X. Nan, M.S. Jin, S.J. Youn, Y.H. Ryu, S. Mah, S.H. Han, H. Lee, S.G. Paik, and J.O. Lee Recognition of lipopeptide patterns by Toll-like receptor 2-Toll-like receptor 6 heterodimer Immunity 31 2009 873 884
42. H.D. Brightbill, D.H. Libraty, S.R. Krutzik, R.B. Yang, J.T. Belisle, J.R. Bleharski, M. Maitland, M.V. Norgard, S.E. Plevy, S.T. Smale, P.J. Brennan, B.R. Bloom, P.J. Godowski, and R.L. Modlin Host defense mechanisms triggered by microbial lipoproteins through toll-like receptors Science 285 1999 732 736
43. A. Tschumi, C. Nai, Y. Auchli, P. Hunziker, P. Gehrig, P. Keller, T. Grau, and P. Sander Identification of apolipoprotein N-acyltransferase (Lnt) in mycobacteria J. Biol. Chem. 284 2009 27146 27156
44. J.K. Brulle, T. Grau, A. Tschumi, Y. Auchli, R. Burri, S. Polsfuss, P.M. Keller, P. Hunziker, and P. Sander Cloning, expression and characterization of Mycobacterium tuberculosis lipoprotein LprF Biochem. Biophys. Res. Commun. 391 2010 679 684
45. I.C. Sutcliffe, and D.J. Harrington Lipoproteins of Mycobacterium tuberculosis: an abundant and functionally diverse class of cell envelope components FEMS Microbiol. Rev. 28 2004 645 659
46. M.G. Drage, N.D. Pecora, A.G. Hise, M. Febbraio, R.L. Silverstein, D.T. Golenbock, W.H. Boom, and C.V. Harding TLR2 and its co-receptors determine responses of macrophages and dendritic cells to lipoproteins of Mycobacterium tuberculosis Cell Immunol. 258 2009 29 37
47. I.C. Sutcliffe, and N. Shaw Atypical lipoteichoic acids of gram-positive bacteria J. Bacteriol. 173 1991 7065 7069
48. I.C. Sutcliffe The lipoteichoic acids and lipoglycans of Gram-positive Bacteria: a chemotaxonomic perspective Syst. Appl. Microbiol. 17 1994 467 480
49. F.C. Neuhaus, and J. Baddiley A continuum of anionic charge: structures and functions of D-alanyl-teichoic acids in gram-positive bacteria Microbiol. Mol. Biol. Rev. 67 2003 686 723
50. J.W. Greenberg, W. Fischer, and K.A. Joiner Influence of lipoteichoic acid structure on recognition by the macrophage scavenger receptor Infect. Immun. 64 1996 3318 3325
51. S. Morath, A. Geyer, and T. Hartung Structure-function relationship of cytokine induction by lipoteichoic acid from Staphylococcus aureus J. Exp. Med. 193 2001 393 397
52. S. Morath, A. Geyer, I. Spreitzer, C. Hermann, and T. Hartung Structural decomposition and heterogeneity of commercial lipoteichoic Acid preparations Infect. Immun. 70 2002 938 944
53. H. Iwasaki, A. Shimada, and E. Ito Comparative studies of lipoteichoic acids from several Bacillus strains J. Bacteriol. 167 1986 508 516
54. M. Cot, A. Ray, M. Gilleron, A. Vercellone, G. Larrouy-Maumus, E. Armau, S. Gauthier, G. Tiraby, G. Puzo, and J. Nigou Lipoteichoic acid in Streptomyces hygroscopicus: structural model and immunomodulatory activities PLoS One 6 2011 e26316
55. K. Uchikawa, I. Sekikawa, and I. Azuma Structural studies on lipoteichoic acids from four Listeria strains J. Bacteriol. 168 1986 115 122
56. O. Dehus, M. Pfitzenmaier, G. Stuebs, N. Fischer, W. Schwaeble, S. Morath, T. Hartung, A. Geyer, and C. Hermann Growth temperature-dependent expression of structural variants of Listeria monocytogenes lipoteichoic acid Immunobiology 216 2011 24 31
57. C. Theilacker, Z. Kaczynski, A. Kropec, F. Fabretti, T. Sange, O. Holst, and J. Huebner Opsonic antibodies to Enterococcus faecalis strain 12030 are directed against lipoteichoic acid Infect. Immun. 74 2006 5703 5712
58. C. Theilacker, P. Sanchez-Carballo, I. Toma, F. Fabretti, I. Sava, A. Kropec, O. Holst, and J. Huebner Glycolipids are involved in biofilm accumulation and prolonged bacteraemia in Enterococcus faecalis Mol. Microbiol. 71 2009 1055 1069
59. K.S. Doran, E.J. Engelson, A. Khosravi, H.C. Maisey, I. Fedtke, O. Equils, K.S. Michelsen, M. Arditi, A. Peschel, and V. Nizet Blood-brain barrier invasion by group B Streptococcus depends upon proper cell-surface anchoring of lipoteichoic acid J. Clin. Invest. 115 2005 2499 2507
60. R.R. Schmidt, C.M. Pedersen, Y. Qiao, and U. Zahringer Chemical synthesis of bacterial lipoteichoic acids: an insight on its biological significance Org. Biomol. Chem. 9 2011 2040 2052
61. H.S. Seo, R.T. Cartee, D.G. Pritchard, and M.H. Nahm A new model of pneumococcal lipoteichoic acid structure resolves biochemical, biosynthetic, and serologic inconsistencies of the current model J. Bacteriol. 190 2008 2379 2387
62. N.T. Reichman, and A. Grundling Location, synthesis and function of glycolipids and polyglycerolphosphate lipoteichoic acid in Gram-positive bacteria of the phylum Firmicutes FEMS Microbiol. Lett. 319 2011 97 105
63. T. Behr, W. Fischer, J. Peter-Katalinic, and H. Egge The structure of pneumococcal lipoteichoic acid. Improved preparation, chemical and mass spectrometric studies Eur. J. Biochem. 207 1992 1063 1075
64. I. Ginsburg Role of lipoteichoic acid in infection and inflammation Lancet Infect. Dis. 2 2002 171 179
65. H.S. Seo, S.M. Michalek, and M.H. Nahm Lipoteichoic acid is important in innate immune responses to gram-positive bacteria Infect. Immun. 76 2008 206 213
66. C. Hermann, I. Spreitzer, N.W. Schroder, S. Morath, M.D. Lehner, W. Fischer, C. Schutt, R.R. Schumann, and T. Hartung Cytokine induction by purified lipoteichoic acids from various bacterial species-role of LBP, sCD14, CD14 and failure to induce IL-12 and subsequent IFN-gamma release Eur. J. Immunol. 32 2002 541 551
67. N.W. Schroder, S. Morath, C. Alexander, L. Hamann, T. Hartung, U. Zahringer, U.B. Gobel, J.R. Weber, and R.R. Schumann Lipoteichoic acid (LTA) of Streptococcus pneumoniae and Staphylococcus aureus activates immune cells via Toll-like receptor (TLR)-2, lipopolysaccharide-binding protein (LBP), and CD14, whereas TLR-4 and MD-2 are not involved J. Biol. Chem. 278 2003 15587 15594
68. M. Mohamadzadeh, E.A. Pfeiler, J.B. Brown, M. Zadeh, M. Gramarossa, E. Managlia, P. Bere, B. Sarraj, M.W. Khan, K.C. Pakanati, M.J. Ansari, S. O'Flaherty, T. Barrett, and T.R. Klaenhammer Regulation of induced colonic inflammation by Lactobacillus acidophilus deficient in lipoteichoic acid Proc. Natl. Acad. Sci. U.S.A. 108 Suppl. 1 2011 4623 4630
69. M. Hashimoto, K. Tawaratsumida, H. Kariya, A. Kiyohara, Y. Suda, F. Krikae, T. Kirikae, and F. Gotz Not lipoteichoic acid but lipoproteins appear to be the dominant immunobiologically active compounds in Staphylococcus aureus J. Immunol. 177 2006 3162 3169
70. U. Zahringer, B. Lindner, S. Inamura, H. Heine, and C. Alexander TLR2-promiscuous or specific? A critical re-evaluation of a receptor expressing apparent broad specificity Immunobiology 213 2008 205 224
71. M. Hashimoto, M. Furuyashiki, R. Kaseya, Y. Fukada, M. Akimaru, K. Aoyama, T. Okuno, T. Tamura, T. Kirikae, F. Kirikae, N. Eiraku, H. Morioka, Y. Fujimoto, K. Fukase, K. Takashige, Y. Moriya, S. Kusumoto, and Y. Suda Evidence of immunostimulating lipoprotein existing in the natural lipoteichoic acid fraction Infect. Immun. 75 2007 1926 1932
72. H.S. Seo, and M.H. Nahm Lipoprotein lipase and hydrofluoric acid deactivate both bacterial lipoproteins and lipoteichoic acids, but platelet-activating factor-acetylhydrolase degrades only lipoteichoic acids Clin. Vaccine Immunol. 16 2009 1187 1195
73. S. Morath, A. Stadelmaier, A. Geyer, R.R. Schmidt, and T. Hartung Synthetic lipoteichoic acid from Staphylococcus aureus is a potent stimulus of cytokine release J. Exp. Med. 195 2002 1635 1640
74. S. Bunk, S. Sigel, D. Metzdorf, O. Sharif, K. Triantafilou, M. Triantafilou, T. Hartung, S. Knapp, and S. von Aulock Internalization and coreceptor expression are critical for TLR2-mediated recognition of lipoteichoic acid in human peripheral blood J. Immunol. 185 2010 3708 3717
75. P. Henneke, S. Morath, S. Uematsu, S. Weichert, M. Pfitzenmaier, O. Takeuchi, A. Muller, C. Poyart, S. Akira, R. Berner, G. Teti, A. Geyer, T. Hartung, P. Trieu-Cuot, D.L. Kasper, and D.T. Golenbock Role of lipoteichoic acid in the phagocyte response to group B streptococcus J. Immunol. 174 2005 6449 6455
76. C.M. Pedersen, I. Figueroa-Perez, J. Boruwa, B. Lindner, A.J. Ulmer, U. Zahringer, and R.R. Schmidt Synthesis of the core structure of the lipoteichoic acid of Streptococcus pneumoniae Chemistry 16 2010 12627 12641
77. C.M. Pedersen, I. Figueroa-Perez, B. Lindner, A.J. Ulmer, U. Zahringer, and R.R. Schmidt Total synthesis of lipoteichoic acid of Streptococcus pneumoniae Angew. Chem. Int. Ed. Engl. 49 2010 2585 2590
78. I.C. Sutcliffe Identification of a lipoarabinomannan-like lipoglycan in Corynebacterium matruchotii Arch. Oral Biol. 40 1995 1119 1124
79. K.J. Gibson, M. Gilleron, P. Constant, B. Sichi, G. Puzo, G.S. Besra, and J. Nigou A lipomannan variant with strong TLR-2-dependent pro-inflammatory activity in Saccharothrix aerocolonigenes J. Biol. Chem. 280 2005 28347 28356
80. D. Chatterjee, and K.H. Khoo Mycobacterial lipoarabinomannan: an extraordinary lipoheteroglycan with profound physiological effects Glycobiology 8 1998 113 120
81. N.J. Garton, M. Gilleron, T. Brando, H.H. Dan, S. Giguere, G. Puzo, J.F. Prescott, and I.C. Sutcliffe A novel lipoarabinomannan from the equine pathogen Rhodococcus equi. Structure and effect on macrophage cytokine production J. Biol. Chem. 277 2002 31722 31733
82. J. Nigou, M. Gilleron, and G. Puzo Lipoarabinomannans: from structure to biosynthesis Biochimie 85 2003 153 166
83. I. Sutcliffe Lipoarabinomannans-structurally diverse and functionally enigmatic macroamphiphiles of mycobacteria and related actinomycetes Tuberculosis (Edinb) 85 2005 205 206
84. M. Gilleron, M. Jackson, J. Nigou, and G. Puzo Structure, biosynthesis and activities of the phosphatidyl-myo-inositol-based lipoglycans M. Daffe, J. Reyrat, The Mycobacterial Cell Envelope 2008 ASM Press Washington DC 75 105
85. A.K. Mishra, N.N. Driessen, B.J. Appelmelk, and G.S. Besra Lipoarabinomannan and related glycoconjugates: structure, biogenesis and role in Mycobacterium tuberculosis physiology and host-pathogen interaction FEMS Microbiol. Rev. 35 2011 1126 1157
86. V. Briken, S.A. Porcelli, G.S. Besra, and L. Kremer Mycobacterial lipoarabinomannan and related lipoglycans: from biogenesis to modulation of the immune response Mol. Microbiol. 53 2004 391 403
87. A. Vercellone, J. Nigou, and G. Puzo Relationships between the structure and the roles of lipoarabinomannans and related glycoconjugates in tuberculosis pathogenesis Front. Biosci. 3 1998 e149 163
88. S. Pitarque, G. Larrouy-Maumus, B. Payre, M. Jackson, G. Puzo, and J. Nigou The immunomodulatory lipoglycans, lipoarabinomannan and lipomannan, are exposed at the mycobacterial cell surface Tuberculosis (Edinb) 88 2008 560 565
89. S. Krishna, A. Ray, S.K. Dubey, G. Larrouy-Maumus, C. Chalut, R. Castanier, A. Noguera, M. Gilleron, G. Puzo, A. Vercellone, K.M. Nampoothiri, and J. Nigou Lipoglycans contribute to innate immune detection of mycobacteria PLoS One 6 2011 e28476
90. J. Nigou, M. Gilleron, M. Rojas, L.F. Garcia, M. Thurnher, and G. Puzo Mycobacterial lipoarabinomannans: modulators of dendritic cell function and the apoptotic response Microbes Infect. 4 2002 945 953
91. V.J. Quesniaux, D.M. Nicolle, D. Torres, L. Kremer, Y. Guerardel, J. Nigou, G. Puzo, F. Erard, and B. Ryffel Toll-like receptor 2 (TLR2)-dependent-positive and TLR2-independent-negative regulation of proinflammatory cytokines by mycobacterial lipomannans J. Immunol. 172 2004 4425 4434
92. C. Vignal, Y. Guerardel, L. Kremer, M. Masson, D. Legrand, J. Mazurier, and E. Elass Lipomannans, but not lipoarabinomannans, purified from Mycobacterium chelonae and Mycobacterium kansasii induce TNF-alpha and IL-8 secretion by a CD14-toll-like receptor 2-dependent mechanism J. Immunol. 171 2003 2014 2023
93. M.P. Puissegur, G. Lay, M. Gilleron, L. Botella, J. Nigou, H. Marrakchi, B. Mari, J.L. Duteyrat, Y. Guerardel, L. Kremer, P. Barbry, G. Puzo, and F. Altare Mycobacterial lipomannan induces granuloma macrophage fusion via a TLR2-dependent, ADAM9- and beta1 integrin-mediated pathway J. Immunol. 178 2007 3161 3169
94. D.M. Underhill, A. Ozinsky, K.D. Smith, and A. Aderem Toll-like receptor-2 mediates mycobacteria-induced proinflammatory signaling in macrophages Proc. Natl. Acad. Sci. U.S.A. 96 1999 14459 14463
95. T.K. Means, E. Lien, A. Yoshimura, S. Wang, D.T. Golenbock, and M.J. Fenton The CD14 ligands lipoarabinomannan and lipopolysaccharide differ in their requirement for Toll-like receptors J. Immunol. 163 1999 6748 6755
96. B.W. Jones, T.K. Means, K.A. Heldwein, M.A. Keen, P.J. Hill, J.T. Belisle, and M.J. Fenton Different Toll-like receptor agonists induce distinct macrophage responses J. Leukoc. Biol. 69 2001 1036 1044
97. M. Gilleron, V.F. Quesniaux, and G. Puzo Acylation state of the phosphatidylinositol hexamannosides from Mycobacterium bovis bacillus Calmette Guerin and mycobacterium tuberculosis H37Rv and its implication in Toll-like receptor response J. Biol. Chem. 278 2003 29880 29889
98. M. Gilleron, J. Nigou, D. Nicolle, V. Quesniaux, and G. Puzo The acylation state of mycobacterial lipomannans modulates innate immunity response through toll-like receptor 2 Chem. Biol. 13 2006 39 47
99. E. Elass, L. Aubry, M. Masson, A. Denys, Y. Guerardel, E. Maes, D. Legrand, J. Mazurier, and L. Kremer Mycobacterial lipomannan induces matrix metalloproteinase-9 expression in human macrophagic cells through a Toll-like receptor 1 (TLR1)/TLR2- and CD14-dependent mechanism Infect. Immun. 73 2005 7064 7068
100. F. Sandor, E. Latz, F. Re, L. Mandell, G. Repik, D.T. Golenbock, T. Espevik, E.A. Kurt-Jones, and R.W. Finberg Importance of extra- and intracellular domains of TLR1 and TLR2 in NFkappa B signaling J. Cell Biol. 162 2003 1099 1110
101. J. Nigou, T. Vasselon, A. Ray, P. Constant, M. Gilleron, G.S. Besra, I. Sutcliffe, G. Tiraby, and G. Puzo Mannan chain length controls lipoglycans signaling via and binding to TLR2 J. Immunol. 180 2008 6696 6702
102. M. Gilleron, J. Nigou, B. Cahuzac, and G. Puzo Structural study of the lipomannans from Mycobacterium bovis BCG: characterisation of multiacylated forms of the phosphatidyl-myo-inositol anchor J. Mol. Biol. 285 1999 2147 2160
103. J. Nigou, M. Gilleron, and G. Puzo Lipoarabinomannans: characterization of the multiacylated forms of the phosphatidyl-myo-inositol anchor by NMR spectroscopy Biochem. J. 337 Pt 3 1999 453 460
104. K.J. Gibson, M. Gilleron, P. Constant, G. Puzo, J. Nigou, and G.S. Besra Structural and functional features of Rhodococcus ruber lipoarabinomannan Microbiology 149 2003 1437 1445
105. K.J. Gibson, M. Gilleron, P. Constant, T. Brando, G. Puzo, G.S. Besra, and J. Nigou Tsukamurella paurometabola lipoglycan, a new lipoarabinomannan variant with pro-inflammatory activity J. Biol. Chem. 279 2004 22973 22982
106. M. Gilleron, N.J. Garton, J. Nigou, T. Brando, G. Puzo, and I.C. Sutcliffe Characterization of a truncated lipoarabinomannan from the Actinomycete Turicella otitidis J. Bacteriol. 187 2005 854 861
107. M. Gilleron, N. Himoudi, O. Adam, P. Constant, A. Venisse, M. Riviere, and G. Puzo Mycobacterium smegmatis phosphoinositols-glyceroarabinomannans. Structure and localization of alkali-labile and alkali-stable phosphoinositides J. Biol. Chem. 272 1997 117 124
108. D. Chatterjee, A.D. Roberts, K. Lowell, P.J. Brennan, and I.M. Orme Structural basis of capacity of lipoarabinomannan to induce secretion of tumor necrosis factor Infect. Immun. 60 1992 1249 1253
109. R.I. Tapping, S. Akashi, K. Miyake, P.J. Godowski, and P.S. Tobias Toll-like receptor 4, but not toll-like receptor 2, is a signaling receptor for Escherichia and Salmonella lipopolysaccharides J. Immunol. 165 2000 5780 5787
110. M. Hirschfeld, Y. Ma, J.H. Weis, S.N. Vogel, and J.J. Weis Cutting edge: repurification of lipopolysaccharide eliminates signaling through both human and murine toll-like receptor 2 J. Immunol. 165 2000 618 622
111. N. Banaiee, E.Z. Kincaid, U. Buchwald, W.R. Jacobs Jr., and J.D. Ernst Potent inhibition of macrophage responses to IFN-gamma by live virulent Mycobacterium tuberculosis is independent of mature mycobacterial lipoproteins but dependent on TLR2 J. Immunol. 176 2006 3019 3027
112. S. Kovacevic, D. Anderson, Y.S. Morita, J. Patterson, R. Haites, B.N. McMillan, R. Coppel, M.J. McConville, and H. Billman-Jacobe Identification of a novel protein with a role in lipoarabinomannan biosynthesis in mycobacteria J. Biol. Chem. 281 2006 9011 9017
113. M.G. Drage, H.C. Tsai, N.D. Pecora, T.Y. Cheng, A.R. Arida, S. Shukla, R.E. Rojas, C. Seshadri, D.B. Moody, W.H. Boom, J.C. Sacchettini, and C.V. Harding Mycobacterium tuberculosis lipoprotein LprG (Rv1411c) binds triacylated glycolipid agonists of Toll-like receptor 2 Nat. Struct. Mol. Biol. 17 2010 1088 1095
114. H. Kanzler, F.J. Barrat, E.M. Hessel, and R.L. Coffman Therapeutic targeting of innate immunity with Toll-like receptor agonists and antagonists Nat. Med. 13 2007 552 559
115. E.J. Hennessy, A.E. Parker, and L.A. O'Neill Targeting Toll-like receptors: emerging therapeutics? Nat. Rev. Drug Discov. 9 2010 293 307
116. B. Pulendran, and R. Ahmed Immunological mechanisms of vaccination Nat. Immunol. 12 2011 509 517
117. S. Basith, B. Manavalan, G. Lee, S.G. Kim, and S. Choi Toll-like receptor modulators: a patent review (2006-2010) Expert Opin. Ther. Pat. 21 2011 927 944